Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered

Recruiting

18 years - 100 years

All

Phase N/A

35 participants needed

1 Location

Brief description of study

HVTN 405/HPTN 1901 will describe immune responses in study participants with a history of recovering from SARS- CoV-2 infection. A main aim of HVTN 405/HPTN 1901 is to develop antibody assays that can be reliably used to detect SARS-CoV-2 infection in vaccine and monoclonal antibody studies to prevent COVID-19. This information will be critical in illuminating the path to the development and testing of safe and effective vaccine and antibody interventions to prevent COVID-19.

Detailed description of study

How will study participants contribute to HVTN 405/HPTN 1901?

Participants will attend one required clinic visit and will have the option to attend additional clinic visits two, four and twelve months after the initial visit.

Each visit includes a questionnaire, blood draw and optional nasal sampling.

Individuals who have not fully recovered from their infection (i.e., still have symptoms or had a positive test within the preceding two weeks) will not be enrolled.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: COVID-19
Age: 18 years - 100 years
Gender: All

Tested positive for COVID-19 by nasopharyngeal, nasal or oral swab.

Updated on 19 Feb 2024. Study ID: 843127

Pre-Screener

Compruebe si es elegible Ingrese los datos de contacto Selecciona un centro de estudios Select best time to contact

Are you over 18 years old?

None

Yes No

Preview complete

The prescreener preview is complete. You may now close the preview.